-
AbbVie’s R&D Convergence Hub
Bio-IT World | The AbbVie R&D Convergence Hub, known as the ARCH, was conceived in 2020 and already the data platform is breaking silos and improving productivity.
Aug 24, 2023
-
Neurosurgeons In Czech Republic Test Writing Capabilities Of ChatGPT
Bio-IT World | Researchers in the Czech Republic succeeded in using ChatGPT (Chat Generative Pre-trained Transformer) to produce a convincing scientific article in only one hour with no special human training—a feat intended to point out the current capabilities of large language models (LLMs).
Aug 23, 2023
-
Gero Taps Quantum Computing and AI To Tackle Diseases Of Aging
Bio-IT World | A movement is afoot to apply quantum computing to the puzzling business of designing drugs with the right molecular properties.
Aug 22, 2023
-
Demographics Matter Under New Diagnostic Paradigm For Breast Cancer
Bio-IT World | In a surprising twist, researchers at Sanford Burnham Prebys have found that both age and sex may matter a great deal when it comes to the consequences of many types of cancer.
Aug 17, 2023
-
Nanopore Sequencing Detects Protein Structures
Bio-IT World | University of Oxford researchers have detected protein structure modifications using nanopore technology.
Aug 16, 2023
-
Researchers Close In On Protein Panel For Predicting Islet Autoimmunity
Bio-IT World | A team of researchers from North America and Europe have identified a panel of 83 markers in the blood of children genetically predisposed to develop type 1 diabetes that looks promising as a predictor of which individuals will progress to islet autoimmunity six months prior to its onset.
Aug 15, 2023
-
New Illumina CTO, Q2 Updates
Bio-IT World | Illumina today announced that Alex Aravanis, CTO, has departed Illumina to pursue an opportunity outside of the company effective immediately. In his place, Steven Barnard, Illumina's Vice President and Head of Global Advanced Science, will serve as its next Chief Technology Officer (CTO).
Aug 9, 2023
-
Using ML to Diagnose Chronic Kidney Disease in a Bias-Free, Privacy-Protecting, Physician-Friendly Manner
Bio-IT World | Carenostics is a healthcare AI startup founded with the mission of addressing the underdiagnosis, undertreatment, and health inequities of chronic disease using AI and ML on existing healthcare data.
Aug 9, 2023
-
Generate Biomedicines’ R&D Data Platform to Support ML-Driven Drug Discovery
Bio-IT World | “Generate Biomedicines’ goal of leveraging machine-learning powered generative biology to discover and develop new drugs faster and cheaper is supported by an integrated and cohesive R&D data platform… FAIR to its core, this integrated data platform leverages industry best practices and lessons-learned from a talented team of informatics engineers to form the critical foundation of a unique company with equal parts ‘bio’ and ‘tech’.”
Aug 8, 2023
-
An AI Tool for Lung Cancer Diagnosis in Indian Populations, Settings
Bio-IT World | The prognosis of lung carcinoma has changed since the discovery of molecular targets and their specific drugs. Somatic EGFR mutations have been reported in lung carcinoma, and these mutant proteins act as substrates for targeted therapies.
Aug 3, 2023
-
Discovery To Creation: Highlights from the 2023 Single-Cell and AI in Medicine Symposium
Bio-IT World | The field of drug discovery is shifting its approach from viewing complex biology as something to be overcome using reductionist principles to something to embrace in a more holistic approach to cell biology.
Aug 2, 2023
-
Platform Reduces Barriers Biologists Face In Accessing Machine Learning
Bio-IT World | A group of scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard University and MIT are convinced that automated machine learning (autoML) is going to revolutionize biology by removing many of the technical barriers to using computational models to answer fundamental questions about sequences of nucleic acids, peptides, and glycans.
Aug 1, 2023
-
Illumina Announces New Genomics Alliance, Software for Analyzing Genomic Data, Understanding Disease Molecules, More
Bio-IT World | Illumina announces the five founding members of the Alliance of Genomic Discovery and launches the newest version of DRAGEN software, the Allen Institute for Immunology and Eli Lilly team up to better understand disease molecules, and crowd-sourced neuroscience. Plus, product updates, partnerships, and acquisitions from Sinequa, Lifebit, Arrayjet, BioIVT, and more.
Jul 27, 2023
-
Follow the Money: AI Platform for Acute Immune States, Acquisitions, Expanding Solutions Portfolio
Bio-IT World | AI platform used for acute immune states, acquisitions, solutions portfolio expansion, and more.
Jul 26, 2023
-
Jarrod Anderson and the Benefits of AI
Bio-IT World | As industries further explore AI, an abundance of new projects and ideas surface, and it can be difficult to decide where to focus.
Jul 25, 2023
-
Trends from the Trenches Part 2: Data Structures, Habits, and Teams
Bio-IT World | After exploring the infrastructure upheaval of the past year, the annual Trends from the Trenches session at Bio-IT World moved to questions of data and teams.
Jul 20, 2023
-
Vibrating Capsule Repurposed For Assessment of ‘Visceral Acuity’
Bio-IT World | Researchers at the Laureate Institute for Brain Research (Tulsa, Oklahoma) are repurposing a vibrating capsule that is FDA-cleared for treating chronic constipation to study how people sense the hidden signals originating in their gastrointestinal (GI) system.
Jul 19, 2023
-
Trends from the Trenches Part 1: Infrastructure Upheaval
Bio-IT World | After years of threatening to pass the baton, Chris Dagdigian was absent from this year’s Trends from the Trenches session at the 2023 Bio-IT World Conference & Expo.
Jul 18, 2023
-
Procurement and Technology Onboarding: How Big Pharma Picks New Tools
Bio-IT World | A panel of pharma representatives talked about their tech acquisition pipelines last month at the Bio-IT World Conference & Expo. Representatives from Roche, Janssen, and Novartis outlined their strategies for acquiring new technologies and the pitfalls they look for.
Jul 14, 2023
-
European Commission Levies Record Fines on Illumina, GRAIL Merger
Bio-IT World | The European Commission announced this morning that it has fined Illumina and GRAIL approximately €432 million and €1,000 respectively—both record fines—for implementing their proposed merger before approval by the Commission, in breach of EU merger control rules.
Jul 12, 2023